(₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 5590.70 | 5627.50 | 4878.40 | -0.7% | 14.6% |
Total Expenses | 5059.80 | 5075.80 | 4516.50 | -0.3% | 12.0% |
Profit Before Tax | 530.90 | 551.70 | 361.90 | -3.8% | 46.7% |
Tax | 156.80 | 161.70 | 108.90 | -3.0% | 44.0% |
Profit After Tax | 379.40 | 395.70 | 254.40 | -4.1% | 49.1% |
Earnings Per Share | 25.90 | 26.30 | 17.10 | -1.5% | 51.5% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Apollo Hospitals Enterprise Ltd is a leading healthcare services provider in India. The company operates a network of hospitals, clinics, and pharmacies across the country, offering a broad range of healthcare services. Its core offerings include specialized medical treatments, surgical procedures, and various health care services. The healthcare sector in India is rapidly growing due to increasing health awareness among the population and government initiatives to improve healthcare facilities. Apollo Hospitals has been at the forefront of this growth, leveraging its extensive network and expertise. Recent developments in the company include expansion into new markets and the integration of advanced healthcare technologies to enhance patient care. However, specific recent developments for this quarter are not available in the data provided.
In the third quarter of the fiscal year 2025, Apollo Hospitals reported a total income of ₹5590.70 crores. This represents a slight decrease of 0.7% compared to the previous quarter (Q2FY25), where the total income was ₹5627.50 crores. Despite this quarter-over-quarter decline, the year-over-year comparison shows a substantial increase of 14.6% from the total income of ₹4878.40 crores reported in the same quarter of the previous fiscal year (Q3FY24). This indicates a robust revenue growth trajectory over the year, reflecting increased demand for healthcare services.
Apollo Hospitals' profitability metrics for Q3FY25 demonstrate a mixed performance. The Profit Before Tax (PBT) for the quarter stood at ₹530.90 crores, which is a 3.8% decline from the previous quarter's PBT of ₹551.70 crores. The Profit After Tax (PAT) for the quarter was ₹379.40 crores, down by 4.1% from the previous quarter's ₹395.70 crores. Despite the quarter-over-quarter decline, the year-over-year figures highlight a significant improvement, with PBT increasing by 46.7% and PAT rising by 49.1% compared to Q3FY24. The Earnings Per Share (EPS) also saw a similar trend, with a slight decrease of 1.5% QoQ to ₹25.90, but a notable increase of 51.5% YoY from ₹17.10 in Q3FY24. The year-over-year growth reflects enhanced operational efficiency and cost management strategies.
Analyzing the operating metrics, the total expenses incurred by Apollo Hospitals in Q3FY25 amounted to ₹5059.80 crores, which is a marginal decrease of 0.3% from the previous quarter's expenses of ₹5075.80 crores. Year-over-year, the expenses have increased by 12% from ₹4516.50 crores in Q3FY24. The tax expenses for the quarter were ₹156.80 crores, witnessing a decrease of 3.0% from the previous quarter's tax of ₹161.70 crores, while showing a 44.0% increase from ₹108.90 crores in Q3FY24. This indicates that while there has been a control in quarterly expenditure, the year-over-year increase in expenses aligns with the growth in total income, suggesting expansion and scaling of operations. The financial ratios, including P/E ratio and other metrics, would require additional data for precise calculation and are not provided in this dataset.